Cover Image
市場調查報告書

乾癬:全球臨床實驗檢討

Psoriasis Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 240575
出版日期 內容資訊 英文 765 Pages
訂單完成後即時交付
價格
Back to Top
乾癬:全球臨床實驗檢討 Psoriasis Global Clinical Trials Review, H2, 2015
出版日期: 2015年11月25日 內容資訊: 英文 765 Pages
簡介

本報告提供全球乾癬治療藥物臨床實驗相關調查,不同地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 乾癬
  • 報告指南
  • 臨床實驗 , 各地區
  • 臨床實驗 , 各國
  • - 亞太地區對臨床實驗有所貢獻的主要5個國家
  • - 歐洲對臨床實驗有所貢獻的主要5個國家
  • 對臨床實驗有所貢獻的主要國家 - 北美
  • - 中東及非洲對臨床實驗有所貢獻的主要5個國家
  • - 中南美對臨床實驗有所貢獻的主要5個國家
  • 臨床實驗 金磚四國 各國
  • 臨床實驗 G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 臨床實驗 E7 各國
  • 臨床實驗 - E7 各國 , 各臨床實驗狀態
  • 各階段臨床實驗
  • 進行中的臨床實驗 各階段
  • 臨床實驗 , 各臨床實驗狀態
  • 未完成的臨床實驗; 乾癬
  • 每段時期的實驗人數
  • 有力的贊助商
  • 參加主要企業 - 乾癬 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 主要企業
  • LEO Pharma A/S
  • 臨床實驗概要; LEO Pharma A/S
  • Abbott Laboratories
  • 臨床實驗概要; Abbott Laboratories
  • Pfizer Inc.
  • 臨床實驗概要; Pfizer Inc.
  • Merck & Co., Inc.
  • 臨床實驗概要; Merck & Co., Inc.
  • Amgen Inc.
  • 臨床實驗概要; Amgen Inc.
  • Astellas
  • 臨床實驗概要; Astellas
  • Genentech, Inc.
  • 臨床實驗概要; Genentech, Inc.
  • Galderma S.A.
  • 臨床實驗概要; Galderma S.A.
  • Janssen Biotech, Inc.
  • 臨床實驗概要; Janssen Biotech, Inc.
  • Johnson & Johnson
  • 臨床實驗概要; Johnson & Johnson
  • GlaxoSmithKline plc
  • 臨床實驗概要; GlaxoSmithKline plc
  • Anacor Pharmaceuticals, Inc.
  • 臨床實驗概要; Anacor Pharmaceuticals, Inc.
  • Celgene Corporation
  • 臨床實驗概要; Celgene Corporation
  • Bristol-Myers Squibb Company
  • 臨床實驗概要; Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • 臨床實驗概要; Eli Lilly and Company
  • Novartis AG
  • 臨床實驗概要; Novartis AG
  • Merck KGaA
  • 臨床實驗概要; Merck KGaA
  • MedImmune, LLC
  • 臨床實驗概要; MedImmune, LLC
  • Almirall, S.A.
  • 臨床實驗概要; Almirall, S.A.
  • Taro Pharmaceuticals Industries Ltd.
  • 臨床實驗概要; Taro Pharmaceuticals Industries Ltd.
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Rockefeller University
  • 臨床實驗概要; Rockefeller University
  • The Medical University of Graz
  • 臨床實驗概要; The Medical University of Graz
  • University of Medicine and Dentistry New Jersey
  • 臨床實驗概要; University of Medicine and Dentistry New Jersey
  • University of California, San Francisco
  • 臨床實驗概要; University of California, San Francisco
  • University of California, Davis
  • 臨床實驗概要; University of California, Davis
  • Tufts Medical Center
  • 臨床實驗概要; Tufts Medical Center
  • National Taiwan University Hospital
  • 臨床實驗概要; National Taiwan University Hospital
  • Wake Forest University
  • 臨床實驗概要; Wake Forest University
  • Chang Gung Memorial Hospital
  • 臨床實驗概要; Chang Gung Memorial Hospital
  • Erasmus MC
  • 臨床實驗概要; Erasmus MC
  • Massachusetts General Hospital
  • 臨床實驗概要; Massachusetts General Hospital
  • University of Michigan
  • 臨床實驗概要; University of Michigan
  • Dresden University of Technology
  • 臨床實驗概要; Dresden University of Technology
  • Mount Sinai School of Medicine
  • 臨床實驗概要; Mount Sinai School of Medicine
  • Verona University
  • 臨床實驗概要; Verona University
  • University of Pennsylvania
  • 臨床實驗概要; University of Pennsylvania
  • IBSA Institut Biochimique SA
  • 臨床實驗概要; IBSA Institut Biochimique SA
  • Assistance Publique - Hopitaux de Paris
  • 臨床實驗概要; Assistance Publique - Hopitaux de Paris
  • University of California, San Diego
  • 臨床實驗概要; University of California, San Diego
  • University of Rochester
  • 臨床實驗概要; University of Rochester
  • Five 主要 臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • About GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 乾癬 治療藥物市場, 全球市場、 臨床實驗 各地區
  • 乾癬 治療藥物市場, 全球市場、 臨床實驗 , 各國排名
  • 乾癬 治療藥物市場, 全球市場、 進行中的臨床實驗 , 各國排名
  • 乾癬 治療藥物的臨床實驗, 亞太地區, 主要5個國家
  • 乾癬 治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 乾癬 治療藥物的臨床實驗, 北美, 主要國家
  • 乾癬 治療藥物的臨床實驗, 中東及非洲, 主要5個國家
  • 乾癬 治療藥物的臨床實驗, 中南美, 主要5個國家
  • 乾癬 治療藥物的臨床實驗, 金磚四國 各國
  • 乾癬 治療藥物的臨床實驗, G7 各國
  • 乾癬 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 乾癬 治療藥物的臨床實驗, E7 各國
  • 乾癬 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 乾癬 治療藥物市場, 全球市場、 各階段臨床實驗
  • 乾癬 治療藥物市場, 全球市場、 進行中的臨床實驗 各階段
  • 乾癬 治療藥物市場, 全球市場、 臨床實驗 , 各臨床實驗狀態
  • 乾癬 治療藥物市場, 全球市場、 暫時停止的臨床實驗
  • 乾癬 治療藥物市場, 全球市場、 中止的臨床實驗
  • 乾癬 治療藥物市場, 全球市場、 終止的臨床實驗
  • 乾癬 治療藥物的臨床實驗, 全球市場、 平均登計對象人數趨勢
  • 乾癬 治療藥物的臨床實驗, 全球市場、 主要的贊助商
  • 乾癬 治療藥物的臨床實驗, 全球市場、 主要企業 各階段
  • 乾癬 治療藥物的臨床實驗, 全球市場、 臨床實驗, 各有潛力治療藥
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- LEO Pharma A/S
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Abbott Laboratories
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Pfizer Inc.
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Merck & Co., Inc.
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Amgen Inc.
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Astellas
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Genentech, Inc.
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Galderma S.A.
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Janssen Biotech, Inc.
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Johnson & Johnson
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- GlaxoSmithKline plc
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Anacor Pharmaceuticals, Inc.
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Celgene Corporation
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Bristol-Myers Squibb Company
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Eli Lilly and Company
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Novartis AG
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Merck KGaA
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- MedImmune, LLC
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Almirall, S.A.
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Taro Pharmaceuticals Industries Ltd.
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Rockefeller University
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- The Medical University of Graz
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of Medicine and Dentistry New Jersey
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of California, San Francisco
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of California, Davis
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Tufts Medical Center
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- National Taiwan University Hospital
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Wake Forest University
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Chang Gung Memorial Hospital
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Erasmus MC
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Massachusetts General Hospital
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of Michigan
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Dresden University of Technology
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Mount Sinai School of Medicine
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Verona University
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of Pennsylvania
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- IBSA Institut Biochimique SA
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Assistance Publique - Hopitaux de Paris
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of California, San Diego
  • 乾癬 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of Rochester

圖表一覽

圖表一覽

  • 乾癬 治療藥物市場, 全球市場、 臨床實驗 各地區 (%)
  • 乾癬 治療藥物市場, 全球市場、 臨床實驗 , 各國排名
  • 乾癬 治療藥物市場, 全球市場、 進行中的臨床實驗 , 各國排名
  • 乾癬 (%)治療藥物的臨床實驗, 亞太地區, 主要5個國家
  • 乾癬 (%)治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 乾癬 治療藥物的臨床實驗, 北美, 主要國家 (%)
  • 乾癬 (%)治療藥物的臨床實驗, 中東及非洲, 主要5個國家
  • 乾癬 (%)治療藥物的臨床實驗, 中南美, 主要5個國家
  • 乾癬 治療藥物的臨床實驗, 金磚四國 各國 (%)
  • 乾癬 治療藥物的臨床實驗, G7 各國 (%)
  • 乾癬 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 乾癬 治療藥物的臨床實驗, E7 各國 (%)
  • 乾癬 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 乾癬 治療藥物市場, 全球市場、 各階段臨床實驗 (%)
  • 乾癬 治療藥物市場, 全球市場、 進行中的臨床實驗 各階段
  • 乾癬 治療藥物市場, 全球市場、 臨床實驗 , 各臨床實驗狀態
  • 乾癬 治療藥物的臨床實驗, 全球市場、 平均登計對象人數趨勢
  • 乾癬 治療藥物的臨床實驗, 全球市場、 主要的贊助商
  • 乾癬 治療藥物的臨床實驗, 全球市場、 主要企業 各階段
  • 乾癬 治療藥物的臨床實驗, 全球市場、 臨床實驗, 各有潛力治療藥
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3000CTIDB

GlobalData's clinical trial report, "Psoriasis Global Clinical Trials Review, H2, 2015" provides an overview of Psoriasis clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Psoriasis to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Psoriasis to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Psoriasis Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Psoriasis
      • Nov 19, 2015: Dermira Completes Patient Enrollment for Second CIMZIA (certolizumab pegol) Phase 3 Clinical Trial in Psoriasis Program
      • Nov 18, 2015: Vitae Pharmaceuticals Announces Positive Top-Line Results From a Phase 1 Multiple Ascending Dose Trial of VTP-43742
      • Oct 05, 2015: AbbVie Demonstrates Leadership in Dermatology with 26 Abstracts at the European Academy of Dermatology and Venereology Congress
      • Sep 29, 2015: Vitae Pharmaceuticals Initiates Second Part of a Phase 1 Multiple Ascending Dose Study of VTP-43742 in Psoriatic Patients
      • Sep 21, 2015: Provectus Biopharmaceuticals Completes Patient Accrual for PH-10 Phase 2 Clinical Study of Cellular and Immunologic Changes in the Skin
      • Sep 08, 2015: Vitae Pharmaceuticals Announces Positive Top-Line Results From Initial Phase 1 Study of First-in-Class RORyt Inhibitor VTP-43742 in Autoimmune Disorders
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Psoriasis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Psoriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Psoriasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Psoriasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Psoriasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Psoriasis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Psoriasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Psoriasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Psoriasis to Immunology Clinical Trials, G7 Countries (%), 2015*
  • Psoriasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Psoriasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Psoriasis to Immunology Clinical Trials, E7 Countries (%), 2015*
  • Psoriasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Psoriasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Psoriasis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Psoriasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Psoriasis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Psoriasis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Psoriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Psoriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Psoriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Psoriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Psoriasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

List of Figures

  • Psoriasis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Psoriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Psoriasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Psoriasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Psoriasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Psoriasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Psoriasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Psoriasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Psoriasis to Immunology Clinical Trials, G7 Countries (%), 2015*
  • Psoriasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Psoriasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Psoriasis to Immunology Clinical Trials, E7 Countries (%), 2015*
  • Psoriasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Psoriasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Psoriasis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Psoriasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Psoriasis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Psoriasis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Psoriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Psoriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Psoriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Psoriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Psoriasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top